Global Parkinson's Disease (PD) Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Parkinson's Disease (PD) Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Market Segment by Application
1.3.1 Global Parkinson's Disease (PD) Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Family
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Parkinson's Disease (PD) Drugs Market Size (2017-2028)
2.1.1 Global Parkinson's Disease (PD) Drugs Revenue (2017-2028)
2.1.2 Global Parkinson's Disease (PD) Drugs Sales (2017-2028)
2.2 Global Parkinson's Disease (PD) Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Parkinson's Disease (PD) Drugs Sales by Regions (2017-2022)
2.2.2 Global Parkinson's Disease (PD) Drugs Revenue by Regions (2017-2022)
2.3 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Region
2.3.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Parkinson's Disease (PD) Drugs Regions (Countries) Ranking by Market Size
2.5 Parkinson's Disease (PD) Drugs Market Dynamics
2.5.1 Parkinson's Disease (PD) Drugs Market Trends
2.5.2 Parkinson's Disease (PD) Drugs Market Drivers
2.5.3 Parkinson's Disease (PD) Drugs Market Challenges
2.5.4 Parkinson's Disease (PD) Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Parkinson's Disease (PD) Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Parkinson's Disease (PD) Drugs Sales in 2021
3.2 Global Top Manufacturers Parkinson's Disease (PD) Drugs by Revenue
3.2.1 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Parkinson's Disease (PD) Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Parkinson's Disease (PD) Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2021)
3.4 Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Parkinson's Disease (PD) Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
3.7 Key Manufacturers Parkinson's Disease (PD) Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Parkinson's Disease (PD) Drugs Market Size by Type
4.1 Global Parkinson's Disease (PD) Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Parkinson's Disease (PD) Drugs Price by Type (2017-2022)
4.2 Global Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Parkinson's Disease (PD) Drugs Price Forecast by Type (2023-2028)
5 Global Parkinson's Disease (PD) Drugs Market Size by Application
5.1 Global Parkinson's Disease (PD) Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Parkinson's Disease (PD) Drugs Price by Application (2017-2022)
5.2 Global Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Parkinson's Disease (PD) Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parkinson's Disease (PD) Drugs Sales Breakdown by Company
6.1.1 North America Parkinson's Disease (PD) Drugs Sales by Company (2017-2022)
6.1.2 North America Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022)
6.2 North America Parkinson's Disease (PD) Drugs Market Size by Type
6.2.1 North America Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
6.2.2 North America Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
6.3 North America Parkinson's Disease (PD) Drugs Market Size by Application
6.3.1 North America Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
6.3.2 North America Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
6.4 North America Parkinson's Disease (PD) Drugs Market Size by Country
6.4.1 North America Parkinson's Disease (PD) Drugs Sales by Country (2017-2028)
6.4.2 North America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Parkinson's Disease (PD) Drugs Sales Breakdown by Company
7.1.1 Europe Parkinson's Disease (PD) Drugs Sales by Company (2017-2022)
7.1.2 Europe Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022)
7.2 Europe Parkinson's Disease (PD) Drugs Market Size by Type
7.2.1 Europe Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
7.2.2 Europe Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
7.3 Europe Parkinson's Disease (PD) Drugs Market Size by Application
7.3.1 Europe Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
7.3.2 Europe Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
7.4 Europe Parkinson's Disease (PD) Drugs Market Size by Country
7.4.1 Europe Parkinson's Disease (PD) Drugs Sales by Country (2017-2028)
7.4.2 Europe Parkinson's Disease (PD) Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Type
8.2.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Application
8.3.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region
8.4.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
8.4.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Parkinson's Disease (PD) Drugs Sales Breakdown by Company
9.1.1 Latin America Parkinson's Disease (PD) Drugs Sales by Company (2017-2022)
9.1.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022)
9.2 Latin America Parkinson's Disease (PD) Drugs Market Size by Type
9.2.1 Latin America Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
9.2.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
9.3 Latin America Parkinson's Disease (PD) Drugs Market Size by Application
9.3.1 Latin America Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
9.3.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
9.4 Latin America Parkinson's Disease (PD) Drugs Market Size by Country
9.4.1 Latin America Parkinson's Disease (PD) Drugs Sales by Country (2017-2028)
9.4.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Type
10.2.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Application
10.3.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Country
10.4.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products and Services
11.1.5 Boehringer Ingelheim Parkinson's Disease (PD) Drugs SWOT Analysis
11.1.6 Boehringer Ingelheim Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products and Services
11.2.5 GlaxoSmithKline Parkinson's Disease (PD) Drugs SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Novartis Parkinson's Disease (PD) Drugs Products and Services
11.3.5 Novartis Parkinson's Disease (PD) Drugs SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Corporation Information
11.4.2 Teva Pharmaceutical Industries Overview
11.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products and Services
11.4.5 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs SWOT Analysis
11.4.6 Teva Pharmaceutical Industries Recent Developments
11.5 AbbVie
11.5.1 AbbVie Corporation Information
11.5.2 AbbVie Overview
11.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 AbbVie Parkinson's Disease (PD) Drugs Products and Services
11.5.5 AbbVie Parkinson's Disease (PD) Drugs SWOT Analysis
11.5.6 AbbVie Recent Developments
11.6 Abital Pharma
11.6.1 Abital Pharma Corporation Information
11.6.2 Abital Pharma Overview
11.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products and Services
11.6.5 Abital Pharma Parkinson's Disease (PD) Drugs SWOT Analysis
11.6.6 Abital Pharma Recent Developments
11.7 Addex Therapeutics
11.7.1 Addex Therapeutics Corporation Information
11.7.2 Addex Therapeutics Overview
11.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products and Services
11.7.5 Addex Therapeutics Parkinson's Disease (PD) Drugs SWOT Analysis
11.7.6 Addex Therapeutics Recent Developments
11.8 Biogen
11.8.1 Biogen Corporation Information
11.8.2 Biogen Overview
11.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Biogen Parkinson's Disease (PD) Drugs Products and Services
11.8.5 Biogen Parkinson's Disease (PD) Drugs SWOT Analysis
11.8.6 Biogen Recent Developments
11.9 Eisai
11.9.1 Eisai Corporation Information
11.9.2 Eisai Overview
11.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Eisai Parkinson's Disease (PD) Drugs Products and Services
11.9.5 Eisai Parkinson's Disease (PD) Drugs SWOT Analysis
11.9.6 Eisai Recent Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Corporation Information
11.10.2 Eli Lilly Overview
11.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products and Services
11.10.5 Eli Lilly Parkinson's Disease (PD) Drugs SWOT Analysis
11.10.6 Eli Lilly Recent Developments
11.11 F. Hoffmann-La Roche
11.11.1 F. Hoffmann-La Roche Corporation Information
11.11.2 F. Hoffmann-La Roche Overview
11.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Products and Services
11.11.5 F. Hoffmann-La Roche Recent Developments
11.12 H. Lundbeck
11.12.1 H. Lundbeck Corporation Information
11.12.2 H. Lundbeck Overview
11.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Products and Services
11.12.5 H. Lundbeck Recent Developments
11.13 Impax Laboratories
11.13.1 Impax Laboratories Corporation Information
11.13.2 Impax Laboratories Overview
11.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Products and Services
11.13.5 Impax Laboratories Recent Developments
11.14 Kyowa Hakko Kirin
11.14.1 Kyowa Hakko Kirin Corporation Information
11.14.2 Kyowa Hakko Kirin Overview
11.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Products and Services
11.14.5 Kyowa Hakko Kirin Recent Developments
11.15 Otsuka Pharmaceutical
11.15.1 Otsuka Pharmaceutical Corporation Information
11.15.2 Otsuka Pharmaceutical Overview
11.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Products and Services
11.15.5 Otsuka Pharmaceutical Recent Developments
11.16 Pfizer
11.16.1 Pfizer Corporation Information
11.16.2 Pfizer Overview
11.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.16.4 Pfizer Parkinson's Disease (PD) Drugs Products and Services
11.16.5 Pfizer Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Parkinson's Disease (PD) Drugs Value Chain Analysis
12.2 Parkinson's Disease (PD) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parkinson's Disease (PD) Drugs Production Mode & Process
12.4 Parkinson's Disease (PD) Drugs Sales and Marketing
12.4.1 Parkinson's Disease (PD) Drugs Sales Channels
12.4.2 Parkinson's Disease (PD) Drugs Distributors
12.5 Parkinson's Disease (PD) Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Dopamine Agonist
Table 3. Major Manufacturers of Monoamine Oxidase Inhibitors
Table 4. Major Manufacturers of Acetylcholinesterase Inhibitors
Table 5. Major Manufacturers of Glutamate Inhibitors
Table 6. Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Parkinson's Disease (PD) Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Parkinson's Disease (PD) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 13. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Parkinson's Disease (PD) Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Parkinson's Disease (PD) Drugs Market Trends
Table 18. Parkinson's Disease (PD) Drugs Market Drivers
Table 19. Parkinson's Disease (PD) Drugs Market Challenges
Table 20. Parkinson's Disease (PD) Drugs Market Restraints
Table 21. Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 22. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers (2017-2022)
Table 23. Global Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Parkinson's Disease (PD) Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 25. Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2017-2022)
Table 26. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2021)
Table 28. Key Manufacturers Parkinson's Disease (PD) Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Pcs)
Table 29. Key Manufacturers Parkinson's Disease (PD) Drugs Plants/Factories Distribution
Table 30. Key Manufacturers Parkinson's Disease (PD) Drugs Area Served
Table 31. Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table 32. Key Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2017-2022)
Table 35. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2017-2022)
Table 36. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Parkinson's Disease (PD) Drugs Price (K Pcs) by Type (2017-2022)
Table 38. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2023-2028)
Table 39. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2023-2028)
Table 40. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2023-2028)
Table 42. Global Parkinson's Disease (PD) Drugs Price (K Pcs) by Type (2023-2028)
Table 43. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2017-2022)
Table 44. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2017-2022)
Table 45. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Parkinson's Disease (PD) Drugs Price (K Pcs) by Application (2017-2022)
Table 47. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2023-2028)
Table 48. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2023-2028)
Table 49. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2023-2028)
Table 51. Global Parkinson's Disease (PD) Drugs Price (K Pcs) by Application (2023-2028)
Table 52. North America Parkinson's Disease (PD) Drugs Sales by Company (2017-2022) & (K Pcs)
Table 53. North America Parkinson's Disease (PD) Drugs Sales Market Share by Company (2017-2022)
Table 54. North America Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2017-2022)
Table 56. North America Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 57. North America Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 58. North America Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 61. North America Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 62. North America Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 65. North America Parkinson's Disease (PD) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 66. North America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Parkinson's Disease (PD) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Parkinson's Disease (PD) Drugs Sales by Company (2017-2022) & (K Pcs)
Table 69. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Company (2017-2022)
Table 70. Europe Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2017-2022)
Table 72. Europe Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 73. Europe Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 74. Europe Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 77. Europe Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 78. Europe Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 81. Europe Parkinson's Disease (PD) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 82. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Company (2017-2022) & (K Pcs)
Table 85. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 89. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 90. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 93. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 94. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 97. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2023-2028) & (K Pcs)
Table 98. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Parkinson's Disease (PD) Drugs Sales by Company (2017-2022) & (K Pcs)
Table 101. Latin America Parkinson's Disease (PD) Drugs Sales Market Share by Company (2017-2022)
Table 102. Latin America Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2017-2022)
Table 104. Latin America Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 105. Latin America Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 106. Latin America Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 109. Latin America Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 110. Latin America Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 113. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 114. Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Company (2017-2022) & (K Pcs)
Table 117. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 121. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 122. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 125. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 126. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 129. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 130. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 132. Boehringer Ingelheim Corporation Information
Table 133. Boehringer Ingelheim Description and Overview
Table 134. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 135. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product and Services
Table 136. Boehringer Ingelheim Parkinson's Disease (PD) Drugs SWOT Analysis
Table 137. Boehringer Ingelheim Recent Developments
Table 138. GlaxoSmithKline Corporation Information
Table 139. GlaxoSmithKline Description and Overview
Table 140. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 141. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product and Services
Table 142. GlaxoSmithKline Parkinson's Disease (PD) Drugs SWOT Analysis
Table 143. GlaxoSmithKline Recent Developments
Table 144. Novartis Corporation Information
Table 145. Novartis Description and Overview
Table 146. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 147. N

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs